C-20 cyclopropyl vitamin D3 analogs

Current Topics in Medicinal Chemistry

Volumn 6, Issue 12, 2006, Pages 1289-1296

  Uskokovic, Milan R ^a   Manchand, Percy ^a,b,c   Marczak, Stanislaw ^a   Maehr, Hubert ^a   Jankowski, Pawel ^a   Adorini, Luciano ^a   Reddy, G Satyanarayana ^b  

^a Bioxell Inc   (United States)

^b Epimer LLC   (United States)

^c BRISTOL MYERS SQUIBB   (United States)

Author keywords

20 cyclopropyl analogs; Hydrogenation; Prostate tumor; Transactivation; UMR 106 cells

Indexed keywords

20 EPI 1,25 CHOLECALCIFEROL; CALCITRIOL; CALCITRIOL DERIVATIVE; COLECALCIFEROL DERIVATIVE; CYCLOPROPYLCALCITRIOL DERIVATIVE; GAMMA INTERFERON; LEXACALCITOL; UNCLASSIFIED DRUG;

CANCER INHIBITION; CELL STRAIN; CHEMICAL MODIFICATION; DOSE RESPONSE; DRUG METABOLISM; DRUG STRUCTURE; DRUG SYNTHESIS; HUMAN; HYPERCALCEMIA; IMMUNOMODULATION; METHYLATION; NONHUMAN; OXIDATION; PROSTATE TUMOR; PROTEIN SECRETION; REVIEW; STRUCTURE ANALYSIS;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CHOLECALCIFEROL; HUMANS; MALE; MICE; MICE, NUDE; MOLECULAR STRUCTURE; NEOPLASMS, EXPERIMENTAL; PROSTATIC NEOPLASMS; RATS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 33746332711     PISSN: 15680266     EISSN: None     Source Type: Journal    
DOI: 10.2174/156802606777864962     Document Type: Review

References (24)

1. Haussler, M.R. Vitamin D receptors: Nature and function. Ann. Rev. Nutr. 1986, 6, 527-62.
2. Bouillon, R.; Okamura, W.H.; Norman, A.W; Structure-function relationships in the vitamin D endocrine system. Endocr Rev. 1995, 16, 200-57.
3. Nagpal, S.; Na, S.; Rathnachalam, R. Noncalcemic actions of vitamin D receptor ligands. Endocr. Rev. 2005, 26, 662-87.
4. 3 analogs as immunomodulatory agents. Trends Mol. Med. 2002, 8, 174-9.
5. Baggiolini, E. G.; Iacobelli, J. A.; Hennessy, B. M.; Batcho, A.D.; Sereno, J.F.; Uskokovic, M.R. Stereocontrolled total synthesis of 1α,25-dihydroxyergocalciderol. J Org. Chem, 1986, 51, 3098-108.
6. 3 analogues: a novel class of potent regulators of cell growth and immune responses. Biochem. Pharmacol. 1991, 27, 42, 1569-75.
7. 3: an extraordinarily potent inhibitor of leukemic cell growth in vitro. Blood 1994, 84, 1960-7.
8. 3 and its 20-epi analogues (MC 1288, MC 1301, KH 1060), on clonal keratinocyte growth: evidence for differentiation of keratinocyte stem cells and analysis of the modulatory effects of cytokines. Br. J. Pharmacol. 1997, 120, 1119-27.
9. 3 analog combined with 9-cis-retinoic acid markedly inhibits colony growth of prostate cancer cells. Prostate 1999, 40, 141-9.
10. Rochel, N.; Wurtz, J.M.; Mitschler, A.; Klaholz, B.; Moras, D. The crystal structure of the nuclear receptor for vitamin D bound to its natural ligand. Mol. Cell. 2000, 5, 173-9.
11. Tocchini-Valentini, G.; Rochel, N.;Wurtz, J.M.; Mitschler, A.; Moras, D. Crystal structures of the vitamin D receptor complexed to superagonist 20-epi ligands. Proc Natl Acad Sci USA 2001, 98, 5491-6.
12. 3 are associated with enhanced activation of the vitamin D receptor. J. Biol. Chem. 1995, 270, 10551-8.
13. 3 analogues and their 20-epi homologues with the vitamin D receptor. J. Biol. Chem. 1997, 272, 3336-45.
14. Perlman, K. L.; Swenson, R. E.; Paaren, H. E.; Schnoes, H. K.; DeLuca, H. F. Novel synthesis of 19-nor-vitamin D compounds. Tetrahedron Lett. 1991, 32, 7663-6.
15. (a) Manchand, P. S.; Uskokovic, M. R. US patent 6, 492, 353 (December 10, 2002);
16. (b) Maehr, H.; Uskokovic, M. R. Formal desymmetrization of the diastereotopic chains in gemini calcitriol derivatives with two different side chains at C-20. Eur. J. Org. Chem. 2004, 1703-1713.
17. 3 analogs: a unique class of potent inhibitors of proliferation of human prostate, breast and myeloid leukemia cell lines. Anticancer Res. 1999, 19, 1689-97.
18. 3 Analogs, 12th-Workshop on Vitamin D, Abstracts 2003, 62.
19. Uskokovic,M.R.;Baggiolini,E.; Shiuey,S.-J.; Iacobelli, J.; Hennessy, B.; Kiegiel, J.; Daniewski, A. R.; Pizzolato, G.; Courtney, L.F.; Horst, R.L. The 16-ene analogs of 1,25-dihydroxycholecaciferol. Synthesis and biological activity. In Vitamin D Gene Regulation, Structure-Function Analysis and Clinical Application. Proceedings of the Eight Workshop on Vitamin D Paris, France July 5-10, 1991. Norman, A.W.; Bouillon, R.; Thomasset, M. Walter de Gruyter, New York 1991, 139-145.
20. 3 into new metabolites with significant biological activity: Studies in rat osteosarcoma cells (UMR 106 and ROS 17/2.8). J. Cell. Biochem. 2001, 82, 599-609.
21. 3 through C-24 oxidation pathway. Biochem. 1989, 28, 1763-1769.
22. Horst, R.L.; Reinhardt, T.A.; Reddy, G. S. Vitamin D Metabolism. In Vitamin D Eds. Feldman, D.; Glorieux, F. H.; Pike, J.W. Academic Press, Inc. 2005, 15-35.
23. 3 in neonatal human keratinocytes. Steroids 2001, 66(3-5): 441-450.
24. Reddy, G. S.; unpublished observation.